TGFB1 and cancer: Recent evidence has demonstrated that TGF-β1 is a major tumor suppressor in premalignant cells, while in the late stages of cancer progression, TGF-β1 induces epithelial-mesenchymal transition (EMT) and leads to increased metastasis of cancer cells [7–9].